Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

SARS-CoV-2-induced COVID-19 cases have been increasing at an alarming rate (~7.4 million positive cases as on 11th June 2020), causing a high mortality (~4,17,956 deaths as on 11th June 2020) and economic loss (~3.2% shrink in global economy in 2020) across 212 countries globally. The clinical manifestations of this disease are pneumonia, lung injury, inflammation, and severe acute respiratory syndrome (SARS). Currently, there is no vaccine or...